Shu CC - Search Results

1

Optimal duration of anti-TB treatment in patients with diabetes: nine or six months?

Wang JY, Lee MC, Shu CC, Lee CH, Lee LN, Chao KM, Chang FY. Wang JY, et al. Among authors: shu cc. Chest. 2015 Feb;147(2):520-528. doi: 10.1378/chest.14-0918. Chest. 2015. PMID: 25255302 Free article.

2

Mycobacterium tuberculosis and polymorphonuclear pleural effusion: incidence and clinical pointers.

Lin MT, Wang JY, Yu CJ, Lee LN, Yang PC; TAMI Group. Lin MT, et al. Respir Med. 2009 Jun;103(6):820-6. doi: 10.1016/j.rmed.2008.12.023. Epub 2009 Feb 12. Respir Med. 2009. PMID: 19217271 Free article.

3

Clinical significance of isolation of nontuberculous mycobacteria in pulmonary tuberculosis patients.

Huang CT, Tsai YJ, Shu CC, Lei YC, Wang JY, Yu CJ, Lee LN, Yang PC; Tami Group. Huang CT, et al. Among authors: shu cc. Respir Med. 2009 Oct;103(10):1484-91. doi: 10.1016/j.rmed.2009.04.017. Epub 2009 May 21. Respir Med. 2009. PMID: 19467850 Free article.

4

Use of high-dose inhaled corticosteroids is associated with pulmonary tuberculosis in patients with chronic obstructive pulmonary disease.

Shu CC, Wu HD, Yu MC, Wang JT, Lee CH, Wang HC, Wang JY, Lee LN, Yu CJ, Yang PC; Taiwan Anti-Mycobacteria Investigation (TAMI) Group. Shu CC, et al. Medicine (Baltimore). 2010 Jan;89(1):53-61. doi: 10.1097/MD.0b013e3181cafcd3. Medicine (Baltimore). 2010. PMID: 20075705 Free article.

5

Predicting results of mycobacterial culture on sputum smear reversion after anti-tuberculous treatment: a case control study.

Shu CC, Wang JT, Lee CH, Wang JY, Lee LN, Yu CJ. Shu CC, et al. BMC Infect Dis. 2010 Mar 6;10:48. doi: 10.1186/1471-2334-10-48. BMC Infect Dis. 2010. PMID: 20205743 Free PMC article.

6

In-hospital outcome of patients with culture-confirmed tuberculous pleurisy: clinical impact of pulmonary involvement.

Shu CC, Wang JT, Wang JY, Lee LN, Yu CJ. Shu CC, et al. BMC Infect Dis. 2011 Feb 21;11:46. doi: 10.1186/1471-2334-11-46. BMC Infect Dis. 2011. PMID: 21338482 Free PMC article.

7

Trends and predictors of changes in pulmonary function after treatment for pulmonary tuberculosis.

Chung KP, Chen JY, Lee CH, Wu HD, Wang JY, Lee LN, Yu CJ, Yang PC; TAMI Group. Chung KP, et al. Clinics (Sao Paulo). 2011;66(4):549-56. doi: 10.1590/s1807-59322011000400005. Clinics (Sao Paulo). 2011. PMID: 21655745 Free PMC article.

8

Integrated postdischarge transitional care in a hospitalist system to improve discharge outcome: an experimental study.

Shu CC, Hsu NC, Lin YF, Wang JY, Lin JW, Ko WJ. Shu CC, et al. BMC Med. 2011 Aug 17;9:96. doi: 10.1186/1741-7015-9-96. BMC Med. 2011. PMID: 21849018 Free PMC article.

9

Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns.

Shu CC, Lee CH, Hsu CL, Wang JT, Wang JY, Yu CJ, Lee LN; TAMI Group. Shu CC, et al. Lung. 2011 Dec;189(6):467-74. doi: 10.1007/s00408-011-9321-4. Epub 2011 Sep 29. Lung. 2011. PMID: 21956280

10

Risk factors for Mycobacterium chelonae-abscessus pulmonary disease persistence and deterioration.

Lee MR, Keng LT, Shu CC, Lee SW, Lee CH, Wang JY, Lee LN, Yu CJ, Yang PC. Lee MR, et al. Among authors: shu cc. J Infect. 2012 Feb;64(2):228-30. doi: 10.1016/j.jinf.2011.11.006. Epub 2011 Nov 12. J Infect. 2012. PMID: 22101165 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

226 results

Search Page

Filters